The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients
- PMID: 35207429
- PMCID: PMC8878431
- DOI: 10.3390/life12020141
The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients
Abstract
(1) Background: Persistent olfactory (POD) and gustatory (PGD) dysfunctions are one of the most frequent symptoms of long-Coronavirus Disease 2019 but their effect on the quality of life (QoL) of patients is still largely unexplored. (2) Methods: An online survey was administered to individuals who reported to have had SARS-CoV-2 infection at least 6 months prior with persisting COVID-19 symptoms (using the COVID symptom index), including ratings of POD and PGD, and their physical (PCS) and mental (MCS) components of quality of life were assessed using the standardized short form 12 questionnaire (SF-12). (3) Results: Responses from 431 unique individuals were included in the analyses. The most frequent persistent symptoms were: fatigue (185 cases, 42.9%), olfactory dysfunction (127 cases, 29.5%), gustatory dysfunction (96 cases, 22.3%) and muscle pain (83 cases, 19.3%). Respondents who reported persisting muscle pain, joint pain, fatigue, headache, gastrointestinal disturbances, and dyspnea had significantly worse PCS. Those experiencing persistent fatigue and dyspnea also showed significantly lower MCS. Respondents reporting POD or PGD showed significantly worse QoL, but only pertaining to the MCS. Multiple regressions predicted MCS based on olfactory and marginally on gustatory ratings, but not PCS. Age significantly affected the prediction of PCS but not MCS, and gender and temporal distance from the COVID-19 diagnosis had no effect. (4) Conclusions: POD and PGD are frequent symptoms of the long-COVID-19 syndrome and significantly reduce QoL, specifically in the mental health component. This evidence should stimulate the establishment of appropriate infrastructure to support individuals with persistent CD, while research on effective therapies scales up.
Keywords: SARS-CoV-2; ageusia; anosmia; gustatory disorders; long-COVID-19; olfactory disorders; quality of life; smell; taste.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Lechien J.R., Chiesa-Estomba C.M., Beckers E., Mustin V., Ducarme M., Journe F., Marchant A., Jouffe L., Barillari M.R., Cammaroto G., et al. Prevalence and 6-month recovery of olfactory dysfunction: A multicentre study of 1363 COVID-19 patients. J. Intern. Med. 2021;290:451–461. doi: 10.1111/joim.13209. - DOI - PubMed
-
- Bussière N., Mei J., Lévesque-Boissonneault C., Blais M., Carazo S., Gros-Louis F., De Serres G., Dupré N., Frasnelli J. Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: A study of over 700 healthcare workers. Chem. Senses. 2021;46:bjab038. doi: 10.1093/chemse/bjab038. - DOI - PMC - PubMed
-
- Boscolo-Rizzo P., Menegaldo A., Fabbris C., Spinato G., Borsetto D., Vaira L.A., Calvanese L., Pettorelli A., Sonego M., Frezza D., et al. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19. Chem. Senses. 2021;46:bjab006. doi: 10.1093/chemse/bjab006. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
